KDM1A epigenetically enhances RAD51 expression to suppress the STING-associated anti-tumor immunity in esophageal squamous cell carcinoma
Qingyuan Yang, Shiyin Wei, Cen Qiu, Chenjie Han, Zunguo Du, Ning Wu · 2024
Read KDM1A epigenetically enhances RAD51 expression to suppress the STING-associated anti-tumor immunity in esophageal squamous cell carcinoma by Qingyuan Yang, Shiyin Wei, Cen Qiu, Chenjie Han, Zunguo Du, Ning Wu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621790.txt.
Description
Qingyuan Yang and five co-authors report, in a 2024 study, how a gene-control protein helps a throat cancer grow and hide from the immune system. The cancer is esophageal squamous cell carcinoma. The protein, KDM1A, removes marks from histones, the spools that DNA winds around, and so can switch genes on or off.
The team found that blocking KDM1A slowed cancer cell growth in dishes and in mice. The protein lifts a brake mark from the promoter of a repair gene, RAD51, and turns that gene up. It also damps genes that drive swelling and immune attack. High levels of the protein in tissue samples matched shorter survival in early-stage patients, which makes it a candidate marker and drug target.
Catalog record
| CREATOR | Qingyuan Yang, Shiyin Wei, Cen Qiu, Chenjie Han, Zunguo Du, Ning Wu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |